Beneficial Effect of Triple-Drug Combination of Teneligliptin with Metformin and Glimepiride in Patients with Type 2 Diabetes Mellitus
DOI:
https://doi.org/10.48047/Keywords:
Type 2 diabetes mellitus; Teneligliptin; Metformin; Glimepiride; Triple-drug therapy; Glycemic control; HbA1c.IntroductionAbstract
Background: Type 2 diabetes mellitus (T2DM) is a progressive metabolic disorder characterized by insulin resistance and progressive β-cell dysfunction. Although metformin remains the preferred first-line therapy
Downloads
Download data is not yet available.
Downloads
Published
2024-03-20
Issue
Section
Articles




